← Back to Clinical Trials
Recruiting NCT06917339

NCT06917339 Retrospective Analyses of TrakStar Database

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06917339
Status Recruiting
Phase —
Sponsor Neuronetics
Condition Depression
Study Type OBSERVATIONAL
Enrollment 156,000 participants
Start Date 2025-02-25
Primary Completion 2035-12

Trial Parameters

Condition Depression
Sponsor Neuronetics
Study Type OBSERVATIONAL
Phase N/A
Enrollment 156,000
Sex ALL
Min Age 5 Years
Max Age 120 Years
Start Date 2025-02-25
Completion 2035-12
Interventions
NeuroStar Advanced TMS Therapy System

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

In this study, real-world data will be used to better understand the effects patient characteristics, symptoms and TMS protocol parameters have on clinical outcomes with NeuroStar TMS.

Eligibility Criteria

Inclusion Criteria: * Male or female reported in database and not an invalid entry * Age reported and not an invalid entry * Treatment date of November 01, 2008 or later. Exclusion Criteria: • Incomplete information on treatment parameters

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

VIEW ON CLINICALTRIALS.GOV ↗ MORE DEPRESSION TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology